FIND officials recently released a summary about a meeting held in Philadelphia last fall where they discussed creating new diagnostic solutions for Plasmodium vivax malaria.
The main goal of the meeting was to develop a map outlining the needs for diagnosing malaria more accurately. The attendees also wanted to evaluate draft target product profiles (TPPs) to improve the diagnostic tests for the disease.
The current draft TPPs have been significantly changed because of the meeting. The attendees used various pieces of evidence that they presented to show that there are three unique diagnostic needs for the disease. The TPPs have been altered to account for this.
Officials plan to continue revising and finalizing the TPPs throughout the first quarter of 2016. Experts and the public are all allowed to contribute to the TPPs with their comments and opinions. The final TPPs will outline product development for creating optimized diagnostic solutions, educate test manufacturers, and speed the available of the test in countries where malaria is endemic.
In the last 15 years, there have been significant advances made in fighting malaria. In recent years, death rates of malaria have decreased by 48 percent. Unfortunately, even though the rates are falling, Plasmodium vivax malaria has not declined as quickly as P. falciparum.